Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Chevalia Robinson"'
Autor:
Rebekah A. Blakney, Emily E. Ricotta, Dean Follmann, Jessica Drew, Kelly A. Carey, Lisa N. Glass, Chevalia Robinson, Sandra MacDonald, Pamela J. McShane, Kenneth N. Olivier, Kevin Fennelly, D. Rebecca Prevots
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Bronchiectasis is a chronic lung condition frequently associated with nontuberculous mycobacteria pulmonary (NTM) disease. Persons with these conditions are at increased risk of mortality. Patient reported outcome (PRO) instrument
Externí odkaz:
https://doaj.org/article/96efb43fee7e46a09f63df23aebd9f18
Autor:
Rebekah A. Blakney, Emily E. Ricotta, Dean Follmann, Jessica Drew, Kelly A. Carey, Lisa N. Glass, Chevalia Robinson, Sandra MacDonald, Pamela J. McShane, Kenneth N. Olivier, Kevin Fennelly, D. Rebecca Prevots
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-9 (2022)
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-9 (2022)
Background Bronchiectasis is a chronic lung condition frequently associated with nontuberculous mycobacteria pulmonary (NTM) disease. Persons with these conditions are at increased risk of mortality. Patient reported outcome (PRO) instruments and the
Autor:
Abdi Ghaffari, Chevalia Robinson, Joas L. da Silva, Mark Rimkus, Sandra D. MacDonald, Kristijan Bogdanovski, Christine M Mashek, Frederick Montgomery, Ann M Peterson, Kenneth N. Olivier, Adrian M. Zelazny, Trisha Chau, Shashank Gupta, Windy A Wallin
Publikováno v:
Access Microbiology. 2
Introduction. Mycobacterium abscessus is an emerging pulmonary pathogen with limited treatment options. Nitric oxide (NO) demonstrates antibacterial activity against various bacterial species, including mycobacteria. In this study, we evaluated the e
Autor:
L.N. Glass, Sandra D. MacDonald, Kenneth N. Olivier, K. Mayer-Barber, Kevin P. Fennelly, Chevalia Robinson, R. Prevots
Publikováno v:
C106. BASIC AND TRANSLATIONAL DISCOVERIES IN TB AND MYCOBACTERIAL DISEASES.
Autor:
Ling Sun, Gang Chen, Charles R. Esther, Kristijan Bogdanovski, Brian Button, Alexandra F. Freeman, Chevalia Robinson, Matthew C. Wolfgang, Wanda K. O'Neal, Kathryn A. Ramsey, Nancy L. Quinney, Richard C. Boucher, Kenneth N. Olivier, Martina Gentzsch, Mehmet Kesimer, David Hill
Publikováno v:
D27. CELLULAR RESPONSES INFORMING LUNG REPAIR.
Autor:
Chevalia Robinson, J.C. Drew, J. Kwan, Sandra D. MacDonald, Emily Ricotta, K.N. Olivier, K.P. Fennelly, R. Prevots, K.A. Carey
Publikováno v:
C105. BRONCHIECTASIS: FROM CLINICAL PHENOTYPES TO TREATMENT.
Autor:
Chevalia Robinson, Leila Jamal, K.P. Fennelly, Robert M. May, David Goldstein, K. Kumar, Magdalena Walkiewicz, Morgan Similuk, K.N. Olivier, Sandra D. MacDonald
Publikováno v:
C105. BRONCHIECTASIS: FROM CLINICAL PHENOTYPES TO TREATMENT.
Autor:
Roscoe O. Brady, Chevalia Robinson, Jessica Baer, Ehud Goldin, Markus Ries, Raphael Schiffmann, Abdel G. Elkahloun, Monique P. Gelderman, David F. Moore
Publikováno v:
Acta Paediatrica. 97:48-52
Aim: This study was designed to examine the effect of enzyme replacement therapy (ERT) on differential gene expression in peripheral blood mononuclear cells (PBMCs) of children with Fabry disease who had not previously been exposed to ERT. Methods: T
Autor:
Chevalia Robinson, Y. Howard Lien, Roscoe O. Brady, Bradley L. Schlaggar, Gregory M. Pastores, Margaret Timmons, Markus Ries, Michael Beck, Joe T.R. Clarke, Raphael Schiffmann, Christoph Kampmann, Catharina Whybra
Publikováno v:
Pediatrics. 118:924-932
CONTEXT. Fabry disease is an X-linked multisystem disorder. Enzyme-replacement therapy in adults has limited efficacy in treating major sequelae of advanced Fabry disease, such as kidney failure or stroke. This prompted a study of the safety and effi
Autor:
Roscoe O. Brady, Markus Ries, David F. Moore, Donna M. Krasnewich, Raphael Schiffmann, Kenneth N. Rosenbaum, Chevalia Robinson, Cynthia J. Tifft
Publikováno v:
Genetics in Medicine. 8:96-101
Purpose: 1) To identify morphometric characteristics in hemizygous patients with Fabry disease a treatable lysosomal storage disorder caused by the deficiency of α-galactosidase A where morphological abnormalities have occasionally been mentioned, b